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H2AX  is a biomarker  of  DNA  double  strand  breaks  conserved  across  eukaryotes.
H2AX  detection  by  High  Content  Screening  can  offer  high  throughput  and  sensitivity.
The  H2AX  assay  was  applied  for  cigarette  smoke  toxicants  genotoxicity  evaluation.
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a  b  s  t  r  a  c  t
Cigarette  smoke  is  a complex  mixture  consisting  of  more  than  5600  identiﬁed  chemical  constituents
of  which  approximately  150  have  been  identiﬁed  so  far  as  “tobacco  smoke  toxicants”.  Proposals  made
by  the  World  Health  Organisation  Framework  Convention  on Tobacco  Control  mandate  the  lowering
of  nine  tobacco  smoke  priority  toxicants,  including  4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNK),  N-nitrosonornicotine  (NNN),  and  benzo[a]pyrene  (B[a]P)  and  monitoring  the  levels  of  a  further
nine including  cadmium.
Here,  we evaluated  the genotoxic  potential  in human  bronchial  epithelial  BEAS-2B  cells  of  four  cigarette
smoke  toxicants;  NNK,  NNN, B[a]P  and  cadmium  using  the novel  in  vitro  H2AX  assay  by High  ContentH2AX
igarette smoke
obacco regulation
Screening  (HCS).  We  also  examined  the  genotoxicity  of binary  mixtures  of  NNK  and  NNN  reporting  their
relative  contribution  to  the  genotoxic  end-point.
The  results  of  this  preliminary  assessment  showed  that  the  in  vitro  H2AX  assay  by  HCS could  be
used  as  a pre-screening  tool  to  detect  and  quantify  the genotoxicity  effect  of cigarette  smoke  toxicants
individually  and  in binary  mixture.  Moreover,  the data  produced  could  contribute  to the  prioritisation  of
toxicant  reduction  research  in modiﬁed  tobacco  products.
The A© 2013 
. Introduction
Cigarette smoke is a complex mixture consisting of more
han 5600 identiﬁed compounds (Perfetti and Rodgman, 2011), of
hich over 150 are known toxicants (Cunningham et al., 2011).
n 2008, the World Health Organisation Framework Convention
n Tobacco Control (WHO FCTC) published “The scientiﬁc basis
f tobacco product regulation” a report containing recommenda-
ions on tobacco product regulation from a group of international
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experts (TobReg) (WHO, 2008). From the initial report, Burns and
colleagues summarised the proposal in a paper where a list of 18
priority toxicants was  shortlisted based on evidence of their direct
toxicity and their hazard indices as described by Fowles and Dybing
(Burns et al., 2008; Fowles and Dybing, 2003). Of these 18 toxicants,
9 were proposed for mandated lowering, including NNK, NNN, and
B[a]P and 9 were proposed for monitoring (Table 1). Similarly,
the Food and Drug Administration (FDA) Center for Tobacco Prod-
ucts (CTP) has recently drafted a guideline for reporting Harmful
and Potentially Harmful Constituents (HPHCs) in tobacco products.
From the list of 93 established HPHCs (FDA, 2012a), 20 are initially
shortlisted for reporting in the draft guideline (FDA, 2012b). The
WHO  FCTC priority toxicants list and the abbreviated HPHC list
contain 14 toxicants in common as detailed in Table 1.
Open access under CC BY-NC-ND license.Burns et al. further discussed the limitation of the prioritisation
model used which was  established based on individual toxicant
exposure, as opposed to complex mixture, and is mostly based
on animal data. In this context, it is of interest to characterise the
NC-ND license.
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Table  1
Cigarette smoke toxicants. Cigarette smoke is an aerosol composed of condensed-phase particle in a gaseous medium. Compounds with low volatility have been found to be
exclusively in the particulate phase, in the gas phase or partitioned between both phases (vapour).
Priority toxicants (Burns et al., 2008) Abbreviated HPHCs (FDA, 2012a) Chemical family Smoke phase Recommended for
lowering by FCTC
Acetaldehyde Carbonyls Vapour Yes
Acrolein Carbonyls Vapour Yes
Acrylonitrile Organic compounds Vapour No
4-Aminobiphenhyl Aromatic amines Particulate No
–  1-Aminonaphthalene Aromatic amines Particulate No
2-Aminonaphthalene Aromatic amines Particulate No
–  Ammonia Inorganic compound Gas No
–  Arsenic Metal/Metalloid Particulate No
Benzene Volatile hydrocarbons Vapour Yes
Benzo(a)pyrene – B[a]P Polyaromatic hydrocarbons Particulate Yes
1,3-Butadiene Volatile hydrocarbons Vapour Yes
Cadmium Heavy metal Particulate No
Carbon monoxide Organic compounds Gas Yes
Catechol – Phenol Particulate No
Crotonaldehyde Carbonyls Vapour No
Formaldehyde Carbonyls Vapour Yes
–  Isoprene Volatile hydrocarbons Vapour No
–  Nicotine Aza-arenes Particulate No
Hydrogen cyanide – Organic compounds Vapour No
Hydroquinone – Phenol Particulate No
Nitrogen oxides – various – Nitrogen oxides Gas No
NNKa Tobacco speciﬁc nitosamines Particulate Yes
NNNb Tobacco speciﬁc nitrosamines Particulate Yes
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a 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone.
b N′-Nitrosonornicotine.
oxicity of smoke toxicants and mixtures using relevant human
arget tissue to prioritise toxicant reduction. However, the level of
haracterisation proposed along with ethical considerations like
he 3Rs principle (Schechtman, 2002) requires a high throughput
n vitro method to overcome lengthy and expensive testing as well
s being an alternative to animal models.
The aim of this study was to utilise the recently developed
n vitro H2AX assay by High Content Screening (HCS) to eval-
ate the genotoxicity effect, in human lung-derived cells, of a
roup of cigarette smoke toxicants shown to cause genotoxicity
n vitro in the battery of assays described in regulatory guidelines,
uch as International Conference on Harmonisation of Techni-
al Requirements for Registration of Pharmaceuticals for Humans
ICH) (ICH, 2011; IARC, 2012a,b,c). The high throughput scoring
ystem employed was the Cellomics ArrayScan® VTI platform
ThermoScientiﬁc, USA), an automated microscopy system that
ombines cellular image acquisition from multi-well microplates
ith software quantiﬁcation analysis (Taylor, 2010). HCS could
rovide simpliﬁed experimental design that allows a larger num-
er of toxicants and mixtures to be pre-screened for genotoxicity
ffects compared to established regulatory in vitro tests.
The novel in vitro H2AX assay HCS in human lung-derived
EAS-2B cells has been recently described (Garcia-Canton et al.,
013b). Brieﬂy, the phosphorylation of the histone 2AX named
H2AX has been demonstrated to be a sensitive marker of DNA
amage in the form of double strand breaks in different scien-
iﬁc ﬁelds since its discovery in 1998 (Rogakou et al., 1998). In
he ﬁeld of regulatory genotoxicity, the in vitro H2AX assay has
een suggested as a complementary tool to the existing battery
f in vitro assays based on its sensitivity, speciﬁcity and automated
coring (Garcia-Canton et al., 2012; Watters et al., 2009; Smart et al.,
011). Moreover, the use of the human-derived BEAS-2B cells as
he in vitro cell system could provide a more physiologically rele-
ant testing system than existing assays where rodent-derived cell
ines are used routinely. The BEAS-2B cell line was ﬁrst described
y Reddel et al. (1988). BEAS-2B cells have a non-cancerous phe-
otype and wild-type p53 status, both of which are important
dvantages in the measurement of DNA damage response such asVolatile hydrocarbons Vapour No
H2AX (Petitjean et al., 2007; Svetlova et al., 2010; IARC, 2013).
However, the cell line BEAS-2B lacks normal metabolic activity for
the majority of the cytochrome P450 family (Garcia-Canton et al.,
2013a). The lack of metabolic activation could cause some pro-
toxicants to produce a “false negative” response in vitro (Kirkland
et al., 2007). To solve the BEAS-2B metabolic competency lim-
itation, the standardised Aroclor-1254 induced rat S9 mix  was
included in our experimental design as an external source of
metabolic bioactivation.
In this study, we have selected 3 chemicals recommended for
mandated lowering by the FCTC, namely B[a]P, NNK and NNN.
We also tested cadmium, a toxicant recommended for monitoring
by the FCTC. The toxicants belong to polyaromatic hydrocarbons
(PAH), Tobacco-speciﬁc nitrosamines (TSNAs), and heavy metals,
respectively. B[a]P, NNK, NNN and cadmium can be found in the
particulate phase of cigarette smoke and are all classiﬁed by the
international agency for research on cancer (IARC) as Group 1 –
carcinogenic to humans (IARC, 2012a,b,c).
The PAH B[a]P is found in tobacco smoke but also in barbequed
foods, polluted air (both outdoor and indoor) and coal tar-based
pharmaceuticals. The toxic effects associated with B[a]P exposure
are caused by the diol-epoxide metabolite (BPDE) formed as a
result of the CYP1A and CYP1B1 metabolism. This metabolism-
mediated toxicity designates B[a]P as a pro-toxicant. The principal
mechanism of action is the formation of DNA-adducts that could
ultimately lead to mutation and DNA breaks (Alexandrov et al.,
2010). B[a]P was  previously evaluated in the presence of S9
mix  during the assessment of the in vitro H2AX assay by HCS
(Garcia-Canton et al., 2013b). In this study B[a]P was tested in
BEAS-2B cultures where CYP1A1/1B1 were pre-induced using
2,3,7,8-Tetrachlorodibenzodioxin (TCDD) as previously described
(Garcia-Canton et al., 2013a).
The heavy metal Cadmium is absorbed from soil by the tobacco
plant which can accumulate relatively high amounts in its leaves
(Lugon-Moulin et al., 2006). Different in vivo and in vitro studies
deﬁned cadmium as a weak mutagenic compound with vari-
ous mechanisms of action such as causing DNA strand breaks,
inducing oxidative stress and acting as a co-mutagen that increases
icology Letters 223 (2013) 81– 87 83
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Table 2
Genotoxicity evaluation criteria for the in vitro H2AX assay, adapted from Smart
et  al. (2011).
H2AX response Classiﬁcation
>1.5-fold H2AX @ RCC > 25% Genotoxic (+)
<1.5-fold H2AX @ RCC 100–0% Non-genotoxic (–)
>1.5-fold H2AX @ RCC < 25% “False” positive; cytotoxic-drivenC. Garcia-Canton et al. / Tox
he mutagenicity of other compounds by inhibition of DNA-repair
echanisms (Waisberg et al., 2003; Hartwig, 2010). Cadmium also
as the potential to be a spindle poison in vivo i.e. an aneugenic
ompound (Watanabe et al., 1979). However, in vitro studies have
hown conﬂicting results that could be caused by the use of differ-
nt cell lines and differing ranges of tested concentrations (Seoane
nd Dulout, 2001; Lynch and Parry, 1993). In this study, the solu-
le form of cadmium tested was cadmium chloride as it has been
idely used both in vivo and in vitro (IARC, 2012c; Fowler et al.,
010; Forti et al., 2010).
The TSNAs NNK and NNN are present in all tobacco products
s a result of the curing process. The toxicity of NNK and NNN
s mainly caused by their metabolites, formed as a result of the
YP2A6/2A13 metabolism (Hecht and Tricker, 1999). Their mecha-
ism of action is to bind covalently to DNA producing mutations and
trand breaks (Liu et al., 1990; Hecht, 1999). Here we  tested both
SNAs in the presence and absence of S9 mix. We  have also tested
NK-acetate and NNN-acetate as CYP-independent reactive forms
f NNK and NNN respectively. The acetate forms are stable inter-
ediates that do not require cytochrome P450 activity to become
ctivated, instead they are activated by esterase enzyme activity
hich are ubiquitous in mammalian cells (Peterson et al., 2001).
Here, we report and discuss the results obtained from the in
itro H2AX assay by HCS applied to the selected cigarette smoke
oxicants tested individually or for the TSNAs as a binary mixture.
he results obtained support the use of the in vitro H2AX assay by
CS as a high throughput tool to investigate the genotoxicity effect
f cigarette smoke toxicants.
. Materials and methods
.1. Chemicals
All compounds were of the highest available grade. Etoposide (positive control)
CAS 33419-42-0), B(a)P (CAS 50-32-8) and cadmium chloride (CAS 10108-64-2)
ere purchased from Sigma–Aldrich (United Kingdom). NNK (CAS 64091-91-4),
NK-acetate (CAS 127686-49-1), NNN (CAS 80508-23-2) and NNN-acetate (CAS
8743-65-7) were purchased from Toronto Research Chemicals (Canada). Dimethyl
ulfoxide (DMSO) was used as a vehicle at a ﬁnal concentration of 1% v/v in cell
ulture medium. Current guidelines for the genotoxicity testing of pharmaceuticals
ere followed to deﬁne doses and treatment times (ICH, 2011). As a result, the
aximum concentration tested was 1 mM except for B[a]P where the maximum
oncentration was 15 M due to poor solubility and precipitation after treatment.
NNK-acetate and NNN-acetate mixture assessment followed simple binary mix-
ure experimental design. Five different permutations containing a different ratio of
ach TSNA were prepared and each permutation contained 8 separate concentra-
ions.
 100% NNK-acetate
 25% NNK-acetate and 75% NNN-acetate
 100% NNN-acetate
 50% NNK-acetate and 50% NNN-acetate
 75% NNK-acetate and 25% NNN-acetate
For example, to prepare 1 mL  ﬁnal volume of the binary mixture 25% NNK-
cetate and 75% NNN-acetate at a concentration of 1000 M,  0.25 mL of NNK-acetate
olution at a concentration of 1000 M was mixed with 0.75 mL  of NNN-acetate
olution at a concentration of 1000 M.  The same approach was followed for the
est of the binary mixtures.
.2. Cell culture
The human bronchial epithelial cell line BEAS-2B, purchased from ATCC (United
tates), was  seeded into culture vessels that had been pre-coated with 0.03 mg/mL
ureCol® bovine collagen solution (Nutacon, The Netherlands). Cells were main-
ained in Bronchial Epithelial Growth Medium (BEGM®) at 37 ◦C and 5% CO2 in a
umidiﬁed incubator. BEGM® was prepared by supplementing Bronchial Epithelial
asal Medium with growth supplements provided in the manufacturer’s BEGM®ingleQuot® kit (Lonza Group Ltd., Belgium) containing: bovine pituitary extract,
ydrocortisone, human epidermal growth factor, epinephrine, insulin, triiodothyro-
ine, transferrin, gentamicin/amphotericin-B and retinoic acid. BEAS-2B cells were
ultured and expanded in-house. All cultures were negative for mycoplasma. Addi-
ionally, the cells were authenticated using the short tandem repeat proﬁling togenotoxicity
=1.5-fold H2AX @ RCC ≥ 25% Equivocal (±)
conﬁrm the nature of the cell cultures (LGC Standards, United Kingdom) (Nims et al.,
2010).
2.3. Treatment, immunostaining and imaging analysis
The methodology to detect and quantify H2AX by HCS has been previously
described (Garcia-Canton et al., 2013b). Here we introduced a minor variation for
the testing of B[a]P where 2,3,7,8-tetrachlorodibenzodioxin (TCDD) was used as
CYP1A1/1B1 inducer. Brieﬂy, 72 h before B[a]P treatment, cells were seeded into
collagen pre-coated 96-well, black, clear bottom microplates (PerkinElmer, United
Kingdom) at a concentration of 6 × 104 cells/mL and maintained overnight at 37 ◦C in
an  atmosphere of 5% CO2 in air. Then, TCDD was added to the culture media (10 nM
ﬁnal) for a further 48 h. Then, the media containing TCDD was removed and cells
washed with pre-warmed phosphate buffered salt solution prior to treatment with
B[a]P.
Aroclor-induced rat S9 and NADPH cofactor (Moltox United States) (0.5% v/v
ﬁnal concentration in medium) were used as the exogenous source of metabolic
activation for the pro-toxicants NNK and NNN. Preparation of the S9 mix was carried
out  following suppliers’ instructions and as detailed in Garcia-Canton et al. (2013b).
In this study compounds were tested for either 3 h or 24 h. For compounds that
required an external source of metabolic activation compounds were tested with
and  without metabolic activation system for 3 h and 3 h followed by a 24 h recovery
period.
2.4. Data analysis and criteria
All experiments were repeated at least 3 times and results were graphically
represented using GraphPad Prism software v.6
H2AX frequency (response) is reported as ﬂuorescence intensity units. Our
methodology scores whole nuclei ﬂuorescence instead of foci numbers; counting
foci  numbers will decrease the throughput of the assay reducing its potential appli-
cation as a pre-screening tool. In addition, the length of our treatments, i.e. minimum
of  3 h, would have an effect in the heterogeneity of foci size (overlapping of foci)
compromising the sensitivity of the results.
Relative Cell Counts (RCC) as a percentage of the vehicle-treated control are used
as  the measure of cell viability. The vehicle treated cell counts were deﬁned as 100%
cell  viability. The cell counts in the compound treated wells were then compared to
those in the vehicle-treated wells, and the percentage cell viability was calculated.
This comparison against the vehicle control data is referred to as Relative Cell Counts
(RCC).
The  evaluation criteria for this study is described in Table 2, it was initially
presented by Smart et al. for the analysis of H2AX by ﬂow cytometry (Smart et al.,
2011) and recently employed by Garcia-Canton et al. for the analysis of H2AX by
HCS (Garcia-Canton et al., 2013b).
3. Results
The novel in vitro H2AX assay by HCS was used to evaluate
the genotoxicity effect of four cigarette smoke toxicants and the
binary mixture of two  TSNAs. Automated ﬂuorescence microscopy
was selected as the scoring system to detect and quantify the
speciﬁc H2AX immunostaining, used as a marker of DNA dou-
ble strand breaks. The graphical representations below show the
H2AX response obtained after BEAS-2B cells were treated with
the positive control etoposide (Fig. 1), different cigarette smoke
toxicants (Figs. 2–5) and the TSNAs binary mixture (Fig. 6). The
X-axis represents the compound concentration (M) on a loga-
rithmic scale while the Y-axis represents the H2AX frequency in
absolute units (intensity units). RCC representing cell viability are
graphically represented in the supplementary data for clarity.
A range of etoposide concentrations up to 1 mM was  used in this
study as a positive control in all experiments conducted. A sample
dose response is graphically represented in Fig. 1.
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aFig. 1. Etoposide positive control dose response example after 3 h treatment.
B[a]P was tested in both TCDD-induced and non-induced cul-
ures for 3 h and 24 h. Initial range ﬁnder experiments testing up to
 mM showed that B[a]P precipitated at high concentrations (data
ot shown). Therefore, the maximum concentration tested in this
tudy was 15 M.  B[a]P did not produce any increase in H2AX
requency above the vehicle-treated controls after 3 h treatment
n the presence and absence of the inducer TCDD (Fig. 2A and B).
hen B[a]P was tested for 24 h, there was a signiﬁcant increase in
H2AX frequency in both TCDD-induced and non-induced cultures
t concentrations above 0.5 M without any signiﬁcant reduction
n cell viability (RCC > 80%). However, the H2AX frequency in non-
nduced cultures at concentrations above 4 M after 24 h treatment
eturned to vehicle-treated levels (<1.5-fold induction) as illus-
rated in Fig. 2B.
ig. 2. H2AX frequency after treatment with B[a]P. (A) B[a]P treatment in TCDD-induce
hort  treatment (3 h) and circle () represents long treatment (24 h). Hash (#) indicates 
o  the vehicle treated control after long treatment. (a) Indicates the minimum concentrat
ig. 3. H2AX frequency after treatment with NNK. (A) NNK in the presence of S9 mix  a
nd  circle () represents short treatment (3 h) followed by a recovery period (24 h).y Letters 223 (2013) 81– 87
Both tobacco-speciﬁc nitrosamines NNK and NNN failed to
show any statistically signiﬁcant increase in H2AX compared to
the vehicle-treated controls at all timepoints in the presence and
absence of aroclor-induced rat S9 mix. Fig. 3 illustrates the results
obtained for NNK in the presence of S9 mix, the same proﬁle was
obtained for NNN in the presence and absence of S9 mix  (data not
shown).
The results represented in Fig. 4 show that both NNK-acetate
and NNN-acetate produced DNA damage in the form of DSBs.
NNK-acetate (Fig. 4A) produced a signiﬁcant increase in H2AX
frequency compared to the vehicle-treated control at concentra-
tions above 16 M after a 3 h treatment, without reduction in cell
viability (RCC > 90%), at 3 h followed by 24 h recovery period con-
centrations above 125 M showed an increase in H2AX above
1.5-fold with a high reduction in cell viability (RCC ∼ 40%). The
highest concentration tested (1000 M)  produced almost total cell
death after a 3 h treatment followed by 24 h recovery period, this
could explain the high variability observed in the data.
When NNN-acetate was  tested at 3 h there was a positive
response at concentrations above 500 M without a reduction
in cell viability below 90%. NNN-acetate did not produce a posi-
tive response after 3 h treatments followed by 24 h recovery time,
although, a dose-related increase in H2AX frequency and reduc-
tion in cell viability were observed (Fig. 4B).
Fig. 5 illustrates the results obtained after BEAS-2B cells were
treated for 3 h and 24 h with cadmium chloride. A positive response
was observed after 3 h treatment at concentrations above 250 M
(RCC > 40%). After 24 h treatment, concentrations above 16 MThe results obtained after BEAS-2B cells were treated for 3 h
with binary mixtures of NNK-acetate and NNN-acetate are graph-
ically represented in Fig. 6. The binary mixture involved the
d cultures and (B) B[a]P treatment in non-induced cultures. Triangle () represents
the minimum concentration that shows genotoxicity (1.5 fold increase) compared
ion where H2AX frequency reverts to non-genotoxic range (<1.5 fold-induction).
nd (B) NNK in the absence of S9 mix. Triangle () represents short treatment (3 h)
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Fig. 4. H2AX frequency after treatment with the active form of NNK and NNN. (A) NNK-acetate treatment, (B) NNN-acetate treatment. Triangle () represents short treatment
(3  h) and circle () represents short treatment (3 h) followed by a recovery period (24 h). A
to  the vehicle treated control after short treatment. Hash (#) indicates the minimum con
long  treatment.
Fig. 5. H2AX frequency after treatment with cadmium chloride. Triangle () repre-
sents short treatment (3 h) and circle () represents long treatment (24 h). Asterisk
(*)  indicates the minimum concentration that shows genotoxicity compared to the
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cigarette smoke has supported the segregation of the toxicants
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(ehicle treated control after short treatment. (a) Indicates the minimum concentra-
ion that shows cytotoxic-driven genotoxicity after long treatment (RCC < 25%).
esting of 5 different permutations containing different percent-
ges of both NNK-acetate and NNN-acetate. All permutations
ested showed a signiﬁcant increase in the H2AX frequency com-
ared to the vehicle-treated control without a reduction in cell
iability to levels below 60%. NNK-acetate (100%) produced a
ore potent genotoxic response than NNN-acetate (100%) as the
ig. 6. H2AX frequency after 3 h treatments with different ratios of TSNA mixtures. Circle
NN-acetate, square () represents 50% NNK-acetate and 50% NNN-acetate, down-pointi
riangle  () represents 100% NNN-acetate. Asterisk (*) indicates the minimum concentrati
ith  100% NNK-acetate. Dagger (†), section sign (§) and double dagger (‡) indicate the m
ontrol after treatment with 75% NNK-acetate and 25% NNN-acetate, 50% NNK-acetate an
#)  indicates the minimum concentration that shows genotoxicity compared to the vehicsterisk (*) indicates the minimum concentration that shows genotoxicity compared
centration that shows genotoxicity compared to the vehicle treated control after
positive response with NNK-acetate is observed at lower concen-
trations than NNN-acetate. The mixtures tested do not suggest any
compound-to-compound interaction such as synergistic or antag-
onistic effects.
4. Discussion
The objective of this study was  to evaluate the applicabil-
ity of the novel in vitro H2AX assay by HCS for the in vitro
genotoxicity assessment of cigarette smoke toxicants in a high-
throughput approach. Additionally, we  assessed the genotoxicity
effect of a mixture of two TSNAs (acetylated NNK and NNN reac-
tive precursors) developing further understanding of their relative
contribution to the genotoxic response.
Traditionally, the in vitro genotoxic effect of tobacco cigarette
smoke has been widely evaluated by testing the particulate mat-
ter collected on Cambridge ﬁlter pads in animal-derived cell lines
such as CHO or V79. A thorough review on the evaluation of in vitro
assays used for assessing cigarette smoke was published by Johnson
et al. (2009). Although these methods are useful when compar-
ing products, it is not possible to determine which compounds
in the mixture are causing the response or “driving” the toxic-
ity. Fractionation of the different components present in tobaccofrom other compounds present in the mixture as described by
Burns et al. (2008) and the FDA CTP (FDA, 2012a). Nonetheless,
mixture testing is still required to understand potential toxicant
 () represents 100% NNK-acetate, rhomb () represents 75% NNK-acetate and 25%
ng triangle () represents 25% NNK-acetate and 75% NNN-acetate and up-pointing
on that shows genotoxicity compared to the vehicle treated control after treatment
inimum concentration that shown genotoxicity compared to the vehicle treated
d 50% NNN-acetate and 25% NNK-acetate and 75% NNN-acetate respectively. Hash
le treated control after treatment with 100% NNN-acetate.
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nteractions and relative contributions. The information obtained
rom single toxicant and mixture testing would be essential to
rioritise the reduction of cigarette smoke toxicants in modiﬁed
obacco products as recommended by the WHO  FCTC (WHO, 2008).
o date, the information existing on cigarette smoke toxicants are
ainly derived from animal models (in vivo) or current regulatory
n vitro genotoxicity assays such as Ames, micronucleus or mouse
ymphoma assay (MLA). Existing regulatory in vitro genotoxicity
ssays have two main limitations, low throughput and high fre-
uency of false positives, for these reasons newer technologies and
nd-points are currently taken into consideration in the genetic
oxicology ﬁeld (Lynch et al., 2011). The in vitro H2AX assay has
een described as a potential complementary tool to the current
attery of genotoxicity assays, especially as a pre-screening assay,
sing scoring systems such as manual microscopy, ﬂow cytome-
ry and in cell western (Watters et al., 2009; Smart et al., 2011;
udebert et al., 2010). Automated microscopy in the form of High
ontent Screening (HCS) has recently been proposed as an alter-
ative to ﬂow cytometry in the in vitro H2AX assay and offer the
dvantage of a high accuracy (86%), which results from a high sen-
itivity (86–92%) and a high speciﬁcity (80–88%) (Garcia-Canton
t al., 2013b). The use of the in vitro H2AX assay by HCS would
acilitate the analysis of large number of compounds and of mix-
ures.
Here, our results indicate that the in vitro H2AX assay by HCS
as the ability to detect the genotoxicity response from cigarette
moke toxicants in different chemical families such as PAHs (B[a]P),
eavy metals (Cadmium) and CYP-independent forms of TSNAs
NNK-acetate and NNN-acetate). The in vitro H2AX assay by HCS
as also shown the potential to detect and quantify the geno-
oxicity effect of binary mixtures supporting the assessment of
omplex chemical to chemical interactions and the relative con-
ribution to the toxicological end-point. In some cases, an elevated
esponse in H2AX levels was observed at concentrations with low
ell viability. This effect has been associated to mechanisms such
s apoptosis as a result of the fragmentation of cellular DNA that
s part of the programmed cell death sequence (Mukherjee et al.,
006; Darzynkiewicz et al., 2012).
During this study some limitations were observed when aroclor-
nduced rat S9 mix  was used as an external source of metabolic
ctivation for TSNAs. Both NNK and NNN produced a negative
esponse in the presence of the S9 mix  but a positive response
as later obtained when the active intermediates were tested.
he S9 mix  is a standardised hepatic product used routinely in
n vitro testing. However, not all the relevant cytochrome P450s are
resent in this external source of metabolic activation as described
y Easterbrook et al. (2001). They performed a comparison between
roclor-induced rat S9 and human liver microsomes ﬁnding that
he rat S9 lacks 7-hydroxylation activity (equivalent to human
YP2A6). In addition, CYP2A13 enzyme activity is mostly restricted
o the respiratory tissue and therefore not expected in liver S9 mix
Su et al., 2000; Zhang et al., 2007). Both CYP2A6 and CYP2A13
nzymes are required for the activation of NNK and NNN (Hecht,
999), explaining why our experiments did not show any response
or these TSNAs in the presence of S9 mix. Engineered BEAS-2B
ells expressing human cytochrome P450 (Mace et al., 1997; Grosse
t al., 1997), human- and animal-derived lung fractions or puri-
ed CYPs could also be employed as alternatives to standard rat
9. The pros and cons of some of these methodologies in vitro
ave been thoroughly reviewed by Brandon et al. (2003). Cell lines
ith a more comprehensive expression of CYP enzymes such as
he human hepatoma-derived HepaRG cells could be considered
s cell systems (Antherieu et al., 2010). However, these “metabol-
cally competent” cell lines are derived from the liver which in
his case is not an appropriate surrogate for the target organ of
xposure.y Letters 223 (2013) 81– 87
In summary, the in vitro H2AX assay by HCS can be used as
a pre-screening tool for the genotoxicity evaluation of cigarette
smoke toxicants both individually and in mixtures supporting the
ranking of priority toxicants, deﬁned by the WHO  FCTC, and the
HPHCs, deﬁned by the FDA CTP (WHO, 2008; FDA, 2012a). The data
produced could scientiﬁcally support the prioritisation of toxicant
reduction in modiﬁed tobacco products. Furthermore, the in vitro
H2AX assay by HCS can be further developed to be adapted to
aerosol exposure and this could become a more physiologically rel-
evant model in the evaluation of toxicants in the form of gases and
vapours as well as whole cigarette smoke.
Conﬂict of interest
None.
Funding information
This work was supported by Group Research and Development
of British American Tobacco (Investments) Ltd as part of its research
programme focusing on reducing the health impact of tobacco use.
C. Garcia-Canton and C. Meredith are employees of British Ameri-
can Tobacco. A. Anadón is employee of the University Complutense
of Madrid and has not received any funding for this research.
Acknowledgements
The authors thank Mr.  G. Errington for his statistical advice dur-
ing the binary mixtures experimental design, and Dr. E. Minet for
proof reading this manuscript.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.toxlet.
2013.08.024.
References
Alexandrov, K., Rojas, M.,  Satarug, S., 2010. The critical DNA damage by
benzo(a)pyrene in lung tissues of smokers and approaches to preventing its
formation. Toxicol. Lett. 198, 63–68.
Antherieu, S., Chesne, C., Li, R.Y., Camus, S., Lahoz, A., Picazo, L., Turpeinen, M.,  Tolo-
nen, A., Uusitalo, J., Guguen-Guillouzo, C., Guillouzo, A., 2010. Stable expression,
activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Drug Metab. Dispos. 38, 516–525.
Audebert, M.,  Riu, A., Jacques, C., Hillenweck, A., Jamin, E.L., Zalko, D., Cravedi, J.P.,
2010. Use of the gammaH2AX assay for assessing the genotoxicity of polycyclic
aromatic hydrocarbons in human cell lines. Toxicol. Lett. 199, 182–192.
Brandon, E.F., Raap, C.D., Meijerman, I., Beijnen, J.H., Schellens, J.H., 2003. An update
on  in vitro test methods in human hepatic drug biotransformation research:
pros and cons. Toxicol. Appl. Pharmacol. 189, 233–246.
Burns, D.M., Dybing, E., Gray, N., Hecht, S., Anderson, C., Sanner, T., O’Connor, R.,
Djordjevic, M.,  Dresler, C., Hainaut, P., Jarvis, M.,  Opperhuizen, A., Straif, K., 2008.
Mandated lowering of toxicants in cigarette smoke: a description of the World
Health Organization TobReg proposal. Tob. Control 17, 132–141.
Cunningham, F.H., Fiebelkorn, S., Johnson, M.,  Meredith, C., 2011. A novel application
of  the margin of exposure approach: segregation of tobacco smoke toxicants.
Food Chem. Toxicol. 49, 2921–2933.
Darzynkiewicz, Z., Zhao, H., Halicka, H.D., Rybak, P., Dobrucki, J., Wlodkowic, D.,
2012. DNA damage signaling assessed in individual cells in relation to the cell
cycle phase and induction of apoptosis. Crit. Rev. Clin. Lab. Sci. 49, 199–217.
Easterbrook, J., Fackett, D., Li, A.P., 2001. A comparison of aroclor 1254-induced
and uninduced rat liver microsomes to human liver microsomes in phenytoin
O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-
mephenytoin 4′-hydroxylation, chloroxazone 6-hydroxylation and testosterone
6beta-hydroxylation. Chem. Biol. Interact. 134, 243–249.
FDA, 2012a. Harmful and Potentially Harmful Constituents in Tobacco Products
and Tobacco Smoke: Established List, http://www.fda.gov/TobaccoProducts/
GuidanceComplianceRegulatoryInformation/ucm297786.htm# (accessed June
2013).
FDA, 2012b. Reporting Harmful and Potentially Harmful Constituents in Tobacco
Products and Tobacco Smoke Under Section 904(a)(3) of the Federal Food,
icolog
F
F
F
G
G
G
G
H
H
H
I
I
I
I
I
J
K
L
L
LC. Garcia-Canton et al. / Tox
Drug, and Cosmetic Act. http://www.fda.gov/downloads/TobaccoProducts/
GuidanceComplianceRegulatoryInformation/UCM297828.pdf
orti, E., Bulgheroni, A., Cetin, Y., Hartung, T., Jennings, P., Pfaller, W.,  Prieto, P.,
2010. Characterisation of cadmium chloride induced molecular and functional
alterations in airway epithelial cells. Cell Physiol. Biochem. 25, 159–168.
owler, P., Whitwell, J., Jeffrey, L., Young, J., Smith, K., Kirkland, D., 2010. Cadmium
chloride, benzo[a]pyrene and cyclophosphamide tested in the in vitro mam-
malian cell micronucleus test (MNvit) in the human lymphoblastoid cell line TK6
at  Covance laboratories, Harrogate UK in support of OECD draft Test Guideline
487. Mutat. Res. 702, 171–174.
owles, J., Dybing, E., 2003. Application of toxicological risk assessment principles
to  the chemical constituents of cigarette smoke. Tob. Control 12, 424–430.
arcia-Canton, C., Anadon, A., Meredith, C., 2012. gammaH2AX as a novel endpoint to
detect DNA damage: Applications for the assessment of the in vitro genotoxicity
of cigarette smoke. Toxicol. In Vitro 26, 1075–1086.
arcia-Canton, C., Minet, E., Anadon, A., Meredith, C., 2013a. Metabolic characteriza-
tion of cell systems used in in vitro toxicology testing: lung cell system BEAS-2B
as  a working example. Toxicol. In Vitro 27, 1719–1727.
arcia-Canton, C., Anadon, A., Meredith, C., 2013b. Assessment of the in vitro H2AX
assay by High Content Screening as a novel genotoxicity test. Mutat. Res.,
http://dx.doi.org/10.1016/j.mrgentox.2013.08.002 (in press).
rosse, Y., Monje, M.C., Mace, K., Pfeifer, A.M., Pfohl-leszkowicz, A., 1997. Use of
bronchial epithelial cells expressing human cytochrome P450 for study on
metabolism and genotoxicity of ochratoxin A. In Vitro Toxicol. 10, 93–102.
artwig, A., 2010. Mechanisms in cadmium-induced carcinogenicity: recent
insights. Biometals 23, 951–960.
echt, S.S., 1999. DNA adduct formation from tobacco-speciﬁc N-nitrosamines.
Mutat. Res. 424, 127–142.
echt, S.S., Tricker, A.R., 1999. Nitrosamines derived from nicotine and other tobacco
alkaloids. In: John, W.G., Peyton Jacob, I.I.I. (Eds.), Analytical Determination
of  Nicotine and Related Compounds and their Metabolites. Elsevier Science,
Amsterdam, pp. 421–488 (Chapter 11).
ARC, 2012a. IARC monographs on the evaluation of carcinogenic risk to humans.
A  review of human carcinogens: chemical agents and related occupations.
Benzo[a]pyrene. 100F.
ARC, 2012b. IARC monographs on the evaluation of carcinogenic risks to
humans. A review of human carcinogens: personal habits and indoor
combustions. N′-Nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone (NNK). International Agency for Research on Cancer. 100E.
ARC, 2012c. IARC monographs on the evaluation of carcinogenic risk to humans.
A  review of human carcinogens: carcinogenic metals, arsenic, ﬁbres and dust.
Cadmium and Cadmium Compounds. 100C.
ARC, 2013. TP53 Database, http://p53.iarc.fr/ (accessed June 2013).
CH, 2011. Guidance on genotoxicity testing and data interpretation for pharma-
ceuticals intended for human use S2(R1). http://www.ich.org/ﬁleadmin/
Public Web  Site/ICH Products/Guidelines/Safety/S2 R1/Step4/S2R1 Step4.pdf
ohnson, M.D., Schilz, J., Djordjevic, M.V., Rice, J.R., Shields, P.G., 2009. Evaluation
of in vitro assays for assessing the toxicity of cigarette smoke and smokeless
tobacco. Cancer Epidemiol. Biomarkers Prev. 18, 3263–3304.
irkland, D., Pfuhler, S., Tweats, D., Aardema, M.,  Corvi, R., Darroudi, F., Elhajouji, A.,
Glatt, H., Hastwell, P., Hayashi, M.,  Kasper, P., Kirchner, S., Lynch, A., Marzin, D.,
Maurici, D., Meunier, J.R., Muller, L., Nohynek, G., Parry, J., Parry, E., Thybaud,
V.,  Tice, R., van Benthem, J., Vanparys, P., White, P., 2007. How to reduce false
positive results when undertaking in vitro genotoxicity testing and thus avoid
unnecessary follow-up animal tests: report of an ECVAM workshop. Mutat. Res.
628, 31–55.
iu, L.L., Alaoui-Jamali, M.A., el, A.N., Castonguay, A., 1990. Metabolism and DNA sin-
gle  strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
and its analogues in primary culture of rat hepatocytes. Cancer Res. 50,
1810–1816.ugon-Moulin, N., Martin, F., Krauss, M.R., Ramey, P.B., Rossi, L., 2006. Cadmium
concentration in tobacco (Nicotiana tabacum L.) from different countries and its
relationship with other elements. Chemosphere 63, 1074–1086.
ynch, A.M., Parry, J.M., 1993. The cytochalasin-B micronucleus/kinetochore assay
in  vitro: studies with 10 suspected aneugens. Mutat. Res. 287, 71–86.y Letters 223 (2013) 81– 87 87
Lynch, A.M., Sasaki, J.C., Elespuru, R., Jacobson-Kram, D., Thybaud, V., De Boeck,
M.,  Aardema, M.J., Aubrecht, J., Benz, R., Dertinger, S.D., Douglas, G.R., White,
P.A.,  Escobar, P.A., Fornace Jr., A., Honma, M.,  Naven, R.T., Rusling, J.F., Schiestl,
R.H., Walmsley, R.M., Yamamura, E., van Benthem, J., Kim, J.H., 2011. New and
emerging technologies for genetic toxicity testing. Environ. Mol. Mutagen. 52,
205–223.
Mace, K., Offord, E.A., Pfeifer, A.M.A., 1997. Drug metabolism and carcinogen
activation studies with human genetically engineered cells. In: Castell, J.V.,
Gomez-Lechon, M.J. (Eds.), In Vitro Methods in Pharmaceutical Research. Aca-
demic Press, London, pp. 433–456.
Mukherjee, B., Kessinger, C., Kobayashi, J., Chen, B.P., Chen, D.J., Chatterjee, A., Burma,
S.,  2006. DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmen-
tation in mammalian cells. DNA Repair (Amst.) 5, 575–590.
Nims, R.W., Sykes, G., Cottrill, K., Ikonomi, P., Elmore, E., 2010. Short tandem repeat
proﬁling: part of an overall strategy for reducing the frequency of cell misiden-
tiﬁcation. In Vitro Cell Dev. Biol. Anim. 46, 811–819.
Perfetti, T.A., Rodgman, A., 2011. The complexity of tobacco and tobacco smoke.
Contrib. Tob. Res. 24, 215–232.
Peterson, L.A., Spratt, T.E., Shan, W.,  Wang, L., Subotkowski, W.,  Roth, R., 2001.
An improved synthesis of radiolabeled 4-(acetoxymethylnitrosamino)-1-(3-
pyridyl)-1-butanone. J. Label. Comp. Radiopharm. 44, 445–450.
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S.V., Hainaut, P., Olivier, M.,
2007. Impact of mutant p53 functional properties on TP53 mutation patterns and
tumor phenotype: lessons from recent developments in the IARC TP53 database.
Hum. Mutat. 28, 622–629.
Reddel, R.R., Ke, Y., Gerwin, B.I., McMenamin, M.G., Lechner, J.F., Su, R.T., Brash,
D.E., Park, J.B., Rhim, J.S., Harris, C.C., 1988. Transformation of human bronchial
epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or
transfection via strontium phosphate coprecipitation with a plasmid containing
SV40 early region genes. Cancer Res. 48, 1904–1909.
Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., Bonner, W.M., 1998. DNA double-
stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol.
Chem. 273, 5858–5868.
Schechtman, L.M., 2002. Implementation of the 3Rs (reﬁnement, reduction, and
replacement): validation and regulatory acceptance considerations for alterna-
tive toxicological test methods. ILAR J. 43 (Suppl.), S85–S94.
Seoane, A.I., Dulout, F.N., 2001. Genotoxic ability of cadmium, chromium and nickel
salts studied by kinetochore staining in the cytokinesis-blocked micronucleus
assay. Mutat. Res. 490, 99–106.
Smart, D.J., Ahmedi, K.P., Harvey, J.S., Lynch, A.M., 2011. Genotoxicity screening via
the gammaH2AX by ﬂow assay. Mutat. Res. 715, 25–31.
Su, T., Bao, Z., Zhang, Q.Y., Smith, T.J., Hong, J.Y., Ding, X., 2000. Human
cytochrome P450 CYP2A13: predominant expression in the respiratory
tract and its high efﬁciency metabolic activation of a tobacco-speciﬁc car-
cinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 60,
5074–5079.
Svetlova, M.P., Solovjeva, L.V., Tomilin, N.V., 2010. Mechanism of elimination of
phosphorylated histone H2AX from chromatin after repair of DNA double-strand
breaks. Mutat. Res. 685, 54–60.
Taylor, D.L., 2010. A personal perspective on high-content screening (HCS): from the
beginning. J. Biomol. Screen. 15, 720–725.
Waisberg, M., Joseph, P., Hale, B., Beyersmann, D., 2003. Molecular and cellular
mechanisms of cadmium carcinogenesis. Toxicology 192, 95–117.
Watanabe, T., Shimada, T., Endo, A., 1979. Mutagenic effects of cadmium on mam-
malian oocyte chromosomes. Mutat. Res. 67, 349–356.
Watters, G.P., Smart, D.J., Harvey, J.S., Austin, C.A., 2009. H2AX phosphorylation as a
genotoxicity endpoint. Mutat. Res. 679, 50–58.
WHO, 2008. The Scientiﬁc Basis of Tobacco Product Regulation. WHO  Tech-
nical Report Series, no. 951. http://www.who.int/tobacco/global interaction/
tobreg/publications/9789241209519.pdfZhang, X., D’Agostino, J., Wu,  H., Zhang, Q.Y., von, W.L., Murphy, S.E.,
Ding, X., 2007. CYP2A13: variable expression and role in human lung
microsomal metabolic activation of the tobacco-speciﬁc carcinogen 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone. J. Pharmacol. Exp. Ther. 323,
570–578.
